As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Naval News

Thales and Exail Join Forces: Creating an Autonomous Underwater Warfare Powerhouse

Thales has announced a binding agreement to acquire the Gorgé family’s stake in Exail Technologies with a view to launching a ...
The Motley Fool

The most promising business inside SpaceX could be getting bigger

SpaceX had a net loss of $5 billion on $18.7 billion of revenue in 2025, but a look under the hood reveals several different stories. The company's launch services and AI segments generated ...
The Financial Express

Jio Platforms IPO DRHP: 5 key balance sheet realities behind one of India’s biggest ever public offerings

Jio Platforms’ DRHP shows a fresh-issue IPO built to cut debt, reset investor rights and fund AI-led growth—watch the price ...

Is Verizon Communications Inc. (VZ) The Best Dividend Stock to Buy According to Hedge Funds?

On June 27, Verizon Communications Inc. (NYSE:VZ) secured nearly $3.2 billion worth of wireless licenses in a Federal ...